We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-14.6%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$68.5B
AUM Growth
-$9.16B
(-12%)
Cap. Flow
+$4.06B
Cap. Flow
% of AUM
5.93%
Top 10 Holdings %
Top 10 Hldgs %
21.45%
Holding
3,375
New
359
Increased
2,433
Reduced
285
Closed
282
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$124M |
| 2 |
Apple
AAPL
|
+$110M |
| 3 |
Microsoft
MSFT
|
+$104M |
| 4 |
Amazon
AMZN
|
+$71.3M |
| 5 |
Warner Bros
WBD
|
+$69.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$61.6M |
| 2 |
CERN
Cerner Corp
CERN
|
+$50.9M |
| 3 |
NXP Semiconductors
NXPI
|
+$31.4M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$30.4M |
| 5 |
Yum China
YUMC
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Healthcare | 14.42% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
2126
DELISTED
MRC Global
MRC
| $1.04M | ﹤0.01% |
104,347
-10,301
| -9% | -$114K |
|
2127
Compass
COMP
$9.66B
| $1.04M | ﹤0.01% |
+287,630
| New | +$1.57M |
|
|
ITOS
2128
DELISTED
iTeos Therapeutics
ITOS
| $1.04M | ﹤0.01% |
50,391
+7,018
| +16% | +$167K |
|
2129
IMAX
IMAX
$2.66B
| $1.04M | ﹤0.01% |
61,405
-3,247
| -5% | -$52.8K |
|
2130
Goosehead Insurance
GSHD
$2.32B
| $1.03M | ﹤0.01% |
22,655
-238
| -1% | -$13K |
|
|
WW
2131
DELISTED
WW International
WW
| $1.03M | ﹤0.01% |
161,576
+13,311
| +9% | +$112K |
|
2132
First Advantage
FA
$4.12B
| $1.03M | ﹤0.01% |
81,155
+24,287
| +43% | +$384K |
|
|
ECHO
2133
EchoStar
ECHO
$26.2B
| $1.02M | ﹤0.01% |
52,974
+3,545
| +7% | +$80K |
|
|
FPI
2134
Farmland Partners
FPI
$432M
| $1.02M | ﹤0.01% |
73,725
+29,167
| +65% | +$424K |
|
2135
Globalstar
GSAT
$10.8B
| $1.02M | ﹤0.01% |
55,130
+19,030
| +53% | +$353K |
|
2136
Independent Bank Corp
IBCP
$844M
| $1.01M | ﹤0.01% |
52,670
-1,821
| -3% | -$36.2K |
|
2137
DMC Global
BOOM
$157M
| $1.01M | ﹤0.01% |
56,176
+6,406
| +13% | +$157K |
|
2138
Horizon Bancorp
HBNC
$1.04B
| $1.01M | ﹤0.01% |
58,148
+1,714
| +3% | +$30.5K |
|
|
RDFN
2139
DELISTED
Redfin
RDFN
| $1.01M | ﹤0.01% |
122,976
+9,825
| +9% | +$112K |
|
2140
Marcus Corp
MCS
$945M
| $1.01M | ﹤0.01% |
68,285
+2,746
| +4% | +$42.2K |
|
2141
Metropolitan Bank Holding Corp
MCB
$1.15B
| $1.01M | ﹤0.01% |
14,524
+2,150
| +17% | +$178K |
|
|
RNAM
2142
DELISTED
Avidity Biosciences
RNAM
| $1.01M | ﹤0.01% |
69,379
+23,249
| +50% | +$346K |
|
2143
Century Aluminum
CENX
$5.07B
| $1.01M | ﹤0.01% |
136,613
-4,579
| -3% | -$71.2K |
|
2144
Aclaris Therapeutics
ACRS
$869M
| $1M | ﹤0.01% |
71,999
+16,805
| +30% | +$236K |
|
|
EGLE
2145
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1M | ﹤0.01% |
19,306
+8,307
| +76% | +$532K |
|
2146
Douglas Elliman
DOUG
$162M
| $998K | ﹤0.01% |
218,763
+21,574
| +11% | +$119K |
|
2147
BioLife Solutions
BLFS
$1.7B
| $996K | ﹤0.01% |
72,112
+35,914
| +99% | +$527K |
|
2148
Genco Shipping & Trading
GNK
$1.1B
| $996K | ﹤0.01% |
51,527
+9,033
| +21% | +$204K |
|
|
GOOD
2149
Gladstone Commercial Corp
GOOD
$627M
| $983K | ﹤0.01% |
52,188
+2,114
| +4% | +$43K |
|
|
NPTN
2150
DELISTED
NEOPHOTONICS CORP
NPTN
| $983K | ﹤0.01% |
62,482
-4,733
| -7% | -$72.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2022 Portfolio in Review
As of Q2 2022, RhumbLine Advisers held 3,375 positions worth $68.5B, down 12% from $77.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers deployed $4.06B of net new capital in Q2 2022, opening 359 new positions and adding to 2,433 existing holdings. Its largest new stake was Aspen Technology Inc: 81,883 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AT&T, an estimated $61.6M trimmed.
- RhumbLine Advisers's largest Q2 2022 buy was Aspen Technology Inc: 81,883 shares worth $15M.
- RhumbLine Advisers added most to Linde in Q2 2022, an estimated $124M increase.
- RhumbLine Advisers's biggest Q2 2022 reduction was AT&T, cutting an estimated $61.6M.
- RhumbLine Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $50.9M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $68.5B portfolio in Q2 2022.
- RhumbLine Advisers opened 359 new positions and closed 282 in Q2 2022.
- RhumbLine Advisers's portfolio value fell 12% quarter-over-quarter to $68.5B.
Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.